Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats
2011

Role of NR2B NMDA Receptors in Pain from Oxaliplatin in Rats

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Mihara Yuki, Egashira Nobuaki, Sada Hikaru, Kawashiri Takehiro, Ushio Soichiro, Yano Takahisa, Ikesue Hiroaki, Oishi Ryozo

Primary Institution: Department of Pharmacy, Kyushu University Hospital

Hypothesis

The study investigates the involvement of NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats.

Conclusion

Spinal NR2B-containing NMDA receptors are involved in the mechanical allodynia caused by oxaliplatin.

Supporting Evidence

  • Oxaliplatin administration caused mechanical allodynia in rats.
  • NMDA receptor antagonists reversed the pain behavior induced by oxaliplatin.
  • NR2B protein and mRNA levels increased in the spinal cord after oxaliplatin treatment.

Takeaway

When rats were given a chemotherapy drug called oxaliplatin, it made them feel pain when their paws were touched, and blocking certain receptors in their spine helped reduce that pain.

Methodology

Rats were treated with oxaliplatin and various NMDA receptor antagonists were administered to assess their effects on pain behavior using the von Frey test.

Limitations

The study was conducted on rats, which may not fully represent human responses.

Participant Demographics

Male Sprague-Dawley rats weighing 200-250 g.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1744-8069-7-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication